1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Attention Deficit Disorder with Hyperactivity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, G; Castelli, M; Centonze, D; De Chiara, V; Federici, M; Gu, HH; Mercuri, NB; Motta, C; Musella, A; Napolitano, F; Romano, R; Rossi, S; Sacchetti, L; Siracusano, A; Studer, V; Usiello, A | 1 |
1 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dronabinol; Excitatory Amino Acid Antagonists; Food Preferences; Gene Expression Regulation; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Point Mutation; Receptor, Cannabinoid, CB1; Receptors, GABA-B; Sucrose | 2011 |